This review highlights emerging therapeutic strategies targeting neurodegeneration, focusing on inflammation and cellular resilience. The authors examine potential drug candidates and molecular targets addressing age-related neuronal decline.
The article emphasizes the need for multi-target approaches that combine anti-inflammatory and neuroprotective effects to tackle complex neurodegenerative conditions. Examples include modulating immune responses and enhancing neuronal survival pathways.
Such strategies offer hope for diseases like Alzheimer’s and Parkinson’s, where existing treatments are limited. Future research should prioritize translating these innovative approaches into clinical applications.
